Stent‐based tempamine delivery on neointimal formation in a porcine coronary model

References

• Suzuki T., Kopia G., Hayashi S., et al. Stent‐based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation 2001; 104: 1188–93
   PubMed Web of Science ®Google Scholar
• Heldman A. W., Cheng L., Jenkins G. M., et al. Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis. Circulation 2001; 103: 2289–95
   PubMed Web of Science ®Google Scholar
• Morice M. C., Serruys P. W., Sousa J. E., et al. Randomized Study with the Sirolimus‐Coated Bx Velocity Balloon‐Expandable Stent in the Treatment of Patients with de Novo Native Coronary Artery Lesions. A randomized comparison of a sirolimus‐eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346: 1773–80
   PubMed Web of Science ®Google Scholar
• Liu X., Huang Y., Hanet C., et al. Study of antirestenosis with the BiodivYsio dexamethasone‐eluting stent (STRIDE): a first‐in‐human multicenter pilot trial. Catheter Cardiovasc Interv 2003; 60: 172–8
   PubMed Web of Science ®Google Scholar
• Park S. J., Shim W. H., Ho D. S., et al. A paclitaxel‐eluting stent for the prevention of coronary restenosis. N Engl J Med 2003; 348: 1537–45
   PubMed Web of Science ®Google Scholar
• Virmani R., Liistro F., Stankovic G., et al. Mechanism of late in‐stent restenosis after implantation of a paclitaxel derivate–eluting polymer stent system in humans. Circulation 2002; 106: 2649–51
   PubMed Web of Science ®Google Scholar
• Liistro F., Stankovic G., Di Mario C., et al. First clinical experience with a paclitaxel derivate‐eluting polymer stent system implantation for in‐stent restenosis: immediate and long‐term clinical and angiographic outcome. Circulation 2002; 105: 1883–86
   PubMed Web of Science ®Google Scholar
• Virmani R., Kolodgie F. D., Farb A., et al. Drug eluting stents: are human and animal studies comparable?. Heart 2003; 89: 133–8
   PubMed Web of Science ®Google Scholar
• Lee S. H., Szinai I., Carpenter K., et al. In‐vivo biocompatibility evaluation of stents coated with a new biodegradable elastomeric and functional polymer. Coron Artery Dis 2002; 13: 237–41
   PubMed Web of Science ®Google Scholar
• Durand E., Al Haj Zen A., Addad F., et al. Adenovirus‐mediated gene transfer of superoxide dismutase and catalase decreases restenosis after balloon angioplasty. J Vasc Res 2005; 42: 255–65
   PubMed Web of Science ®Google Scholar
• Tardif J. C., Gregoire J., L’Allier P. L. Prevention of restenosis with antioxidants: mechanisms and implications. Am J Cardiovasc Drugs 2002; 2: 323–34
   PubMed Web of Science ®Google Scholar
• Wang L., Salu K., Verbeken E., et al. Stent‐mediated methylprednisolone delivery reduces macrophage contents and in‐stent neointimal formation. Coron Artery Dis 2005; 16: 237–43
   PubMed Web of Science ®Google Scholar
• Schwartz R. S., Huber K. C., Murphy J. G., et al. Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. J Am Coll Cardiol 1992; 19: 267–74
   PubMed Web of Science ®Google Scholar
• Huang Y., Wang L., Verweire I., et al. Optimization of local methylprednisolone delivery to inhibit inflammatory reaction and neointimal hyperplasia of coated coronary stents. J Invasive Cardiol 2002; 14: 505–13
   PubMedGoogle Scholar
• van der Giessen W. J., Lincoff A. M., Schwartz R. S., et al. Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation 1996; 94: 1690–97
   PubMed Web of Science ®Google Scholar
• Whelan D. M., van der Giessen W. J., Krabbendam S. C., et al. Biocompatibility of phosphorylcholine coated stents in normal porcine coronary arteries. Heart 2000; 83: 338–45
   PubMed Web of Science ®Google Scholar
• Holmes D. R., Camrud A. R., Jorgenson M. A., et al. Polymeric stenting in the porcine coronary artery model: differential outcome of exogenous fibrin sleeves versus polyurethane‐coated stents. J Am Coll Cardiol 1994; 24: 525–31
   PubMed Web of Science ®Google Scholar
• Nunes G. L., Robinson K., Kalynych A., et al. Vitamins C and E inhibit O2‐ production in the pig coronary artery. Circulation 1997; 96: 3593–601
   PubMed Web of Science ®Google Scholar
• Azevedo L. C., Pedro M. A., Souza L. C., et al. Oxidative stress as a signaling mechanism of the vascular response to injury: the redox hypothesis of restenosis. Cardiovasc Res 2000; 47: 436–45
   PubMed Web of Science ®Google Scholar
• Raikov Z. D., Raikova E. T., Atanasov A. T. Nitric oxide and free stable nitroxyl radicals in the mechanism of biological action of the spin‐labeled compounds. Med Hypotheses 2001; 57: 302–5
   PubMed Web of Science ®Google Scholar
• Swartz H. M., Sentjurc M., Morse P. D 2nd. Cellular metabolism of water‐soluble nitroxides: effect on rate of reduction of cell/nitroxide ratio, oxygen concentrations and permeability of nitroxides. Biochim Biophys Acta 1986; 888: 82–90
   PubMed Web of Science ®Google Scholar
• Komarov A. M., Joseph J., Lai C. S. In vivo pharmacokinetics of nitroxides in mice. Biochem Biophys Res Commun 1994; 201: 1035–42
   PubMed Web of Science ®Google Scholar
• Hahn S. M., Mitchell J. B., Shacter E. Tempol inhibits neutrophil and hydrogen peroxide‐mediated DNA damage. Free Radic Biol Med 1997; 23: 879–84
   PubMed Web of Science ®Google Scholar
• Zacharowski K., Olbrich A., Cuzzocrea S., et al. Membrane‐permeable radical scavenger, tempol, reduces multiple organ injury in a rodent model of gram‐positive shock. Crit Care Med 2000; 28: 1953–61
   PubMed Web of Science ®Google Scholar
• Samuni A., Winkelsberg D., Pinson A., et al. Nitroxide stable radicals protect beating cardiomyocytes against oxidative damage. J Clin Invest 1991; 87: 1526–30
   PubMed Web of Science ®Google Scholar
• Gariboldi M. B., Lucchi S., Caserini C., et al. Antiproliferative effect of the piperidine nitroxide TEMPAMINEL on neoplastic and nonneoplastic mammalian cell lines. Free Radic Biol Med 1998; 24: 913–23
   PubMed Web of Science ®Google Scholar
• Farb A., Heller P. F., Shroff S., et al. Pathological analysis of local delivery of paclitaxel via a polymer‐coated stent. Circulation 2001; 104: 473–9
   PubMed Web of Science ®Google Scholar